Multicolor Fluorescence-Based Approaches for Imaging Cytokine-Induced Alterations in the Neovascularization, Growth, Metastasis, and Apoptosis of Murine Neuroblastoma Tumors
暂无分享,去创建一个
J. Wigginton | J. Stauffer | T. Back | T. Khan | R. Salcedo | J. Hixon | Jon M Wigginton | Jimmy K Stauffer | Tahira Khan | Rosalba Salcedo | Julie A Hixon | Erin Lincoln | Timothy C Back | Erin Lincoln
[1] S. Gillies,et al. Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy , 2004, Clinical Cancer Research.
[2] J. Ward,et al. Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epithelial Apoptosis1 2 , 2001, The Journal of Immunology.
[3] Michael Bouvet,et al. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer , 2004, Clinical & Experimental Metastasis.
[4] D. Ribatti,et al. Antiangiogenic strategies in neuroblastoma. , 2005, Cancer treatment reviews.
[5] A. Rademaker,et al. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Jenney. Principles and Practice of Pediatric Oncology , 1994 .
[7] Eugene S. Kim,et al. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] Simone Fulda,et al. Apoptosis Signaling in Tumor Therapy , 2004, Annals of the New York Academy of Sciences.
[9] W. Stallcup,et al. Early Contribution of Pericytes to Angiogenic Sprouting and Tube Formation , 2004, Angiogenesis.
[10] S. Kimura,et al. Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models. , 2005, Cancer letters.
[11] K. Matthay,et al. Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[13] K K Matthay,et al. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .
[14] A. Theofilopoulos,et al. Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Wigginton,et al. IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. , 2001, The Journal of clinical investigation.
[16] P. Pizzo,et al. Principles and Practice of Pediatric Oncology , 1989 .
[17] R. Hoffman,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Review Gfp Imaging in Vivo Green Fluorescent Protein Imaging of Tumour Growth, Metastasis, and Angiogenesis in Mouse Models , 2022 .
[18] N. Rubio,et al. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] John M Maris,et al. The biologic basis for neuroblastoma heterogeneity and risk stratification , 2005, Current opinion in pediatrics.
[20] György Hajnóczky,et al. Rapid Kinetics of tBid-induced Cytochrome c and Smac/DIABLO Release and Mitochondrial Depolarization* , 2002, The Journal of Biological Chemistry.
[21] J. Nuchtern,et al. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes. , 2000, Cancer research.
[22] K. Hillan,et al. Neutralizing anti‐vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo , 1998, The Prostate.
[23] Xiaodong Wang,et al. Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.
[24] G. Mohapatra,et al. Targeted expression of MYCN causes neuroblastoma in transgenic mice , 1997, The EMBO journal.
[25] D. Green,et al. The Pathophysiology of Mitochondrial Cell Death , 2004, Science.
[26] Meng Yang,et al. Real‐time whole‐body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein , 2005, The Prostate.
[27] R. Seeger,et al. Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells1 , 2001, The Journal of Immunology.
[28] S. Nilsson,et al. Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology. , 2005, European journal of cancer.
[29] M. Lotze,et al. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo. , 2003, Journal of pediatric surgery.
[30] Hua Yu,et al. Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells1 , 2001, The Journal of Immunology.
[31] R. D'Amato,et al. Inhibition of angiogenesis in vivo by interleukin 12. , 1995, Journal of the National Cancer Institute.
[32] Dai Fukumura,et al. Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.
[33] J. Djeu,et al. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. , 1994, Blood.
[34] S. Gillies,et al. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. , 2003, Blood.
[35] S. Paris,et al. Metastasis models: the green fluorescent revolution? , 2004, Carcinogenesis.
[36] Tomoko Nakanishi,et al. ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.
[37] J. Tschopp,et al. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. , 2000, Cancer research.
[38] F. Behm,et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.
[39] D. Newmeyer,et al. Mitochondria Releasing Power for Life and Unleashing the Machineries of Death , 2003, Cell.
[40] R. Khosravi‐Far. Death receptor signals to the mitochondria , 2004, Cancer biology & therapy.
[41] V. Mootha,et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. , 2000, Genes & development.
[42] S. Cohn,et al. Advances in the diagnosis and treatment of neuroblastoma , 1998, Current opinion in oncology.